Artemisinin combination therapy used to treatment of malaria disease. Malaria is a serious, life threatening disease spread by mosquitoes & causes by a parasite which mainly destroy red blood cell in the body. The artemiisinin combination therapy work with partner drug. The artemisinin compound play important role in reduction of no. of parasites during the 1st three days of treatment (reduction of parasite biomass) and the role of partner drug is to eliminate the remaining parasite. The artemisinin is a drug derived from the Asian plant Artemisia annua.
MARKET DYNAMICS
The artemisinin combination therapy market is expected to grow during the forecast period owing to the key driving factors such as rising demand for artemisinin combination therapy, increasing pollution related problems, the various government initiatives for malaria disease awareness. In addition, various players in the emerging market have strong pipeline product and high potential which are anticipated to create several growth opportunities for the market during the forecast period.
MARKET SCOPE
The "Global Artemisinin Combination Therapy Market Analysis to 2031" is a specialized and in-depth study with a special focus on the global market trend analysis. The report aims to provide an overview of artemisinin combination therapy with detailed market segmentation by type, distribution channel and geography. The global artemisinin combination therapy market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading the artemisinin combination therapy market players and offers key trends and opportunities in the market.
MARKET SEGMENTATION
The global artemisinin combination therapy market is segmented on the basis of type and distribution channels. Based on type, the market is segmented as artemether-lumefantrine, Artesunate-amodiaquine, dihydroartemisinin-piperaquine, artesunate-mefloquine, artesunate-sulfadoxine-pyrimethamine and pyronaridine-artesunate. On the basis of distribution channel the global artemisinin combination therapy market is classify into retail pharmacy, hospitals and others.
REGIONAL FRAMEWORKThe report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global artemisinin combination therapy market based on various segments. It also provides market size and forecast estimates from year 2021 to 2031 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The artemisinin combination therapy market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting artemisinin combination therapy market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the artemisinin combination therapy market in these regions.
Have a question?
Mrinal
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global artemisinin combination therapy market based on various segments. It also provides market size and forecast estimates from year 2021 to 2031 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The artemisinin combination therapy market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting artemisinin combination therapy market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the artemisinin combination therapy market in these regions.
MARKET PLAYERSThe reports cover key developments in the artemisinin combination therapy market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from artemisinin combination therapy market are anticipated to lucrative growth opportunities in the future with the rising demand for artemisinin combination therapy market in the global market. Below mentioned is the list of few companies engaged in the artemisinin combination therapy market.
The report also includes the profiles of key artemisinin combination therapy market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
- Hovid-Integrated Global Pharmaceutical Partner
- Ipca Laboratories Ltd
- Aspen Holdings
- AJANTA PHARMA
- Novartis AG
- Sanofi
- Cipla Inc
- KPC Pharmaceuticals
- Mylan N.V
- Calyx Chemicals and Pharmaceuticals Limited
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Artemisinin Combination Therapy Market - By Type
1.3.2 Artemisinin Combination Therapy Market - By Distribution Channels
1.3.3 Artemisinin Combination Therapy Market - By Region
1.3.3.1 by Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. ARTEMISININ COMBINATION THERAPY MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. ARTEMISININ COMBINATION THERAPY MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS, RESTRAINTS & EXPECTED INFLUENCE OF COVID-19 PANDEMIC
6. ARTEMISININ COMBINATION THERAPY MARKET - GLOBAL MARKET ANALYSIS
6.1. ARTEMISININ COMBINATION THERAPY - GLOBAL MARKET OVERVIEW
6.2. ARTEMISININ COMBINATION THERAPY - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING/MARKET SHARE
7. ARTEMISININ COMBINATION THERAPY MARKET - REVENUE AND FORECASTS TO 2028 - TYPE
7.1. OVERVIEW
7.2. TYPE MARKET FORECASTS AND ANALYSIS
7.3. ARTEMETHER-LUMEFANTRINE
7.3.1. Overview
7.3.2. Artemether-Lumefantrine Market Forecast and Analysis
7.4. ARTESUNATE-AMODIAQUINE
7.4.1. Overview
7.4.2. Artesunate-Amodiaquine Market Forecast and Analysis
7.5. DIHYDROARTEMISININ-PIPERAQUINE
7.5.1. Overview
7.5.2. Dihydroartemisinin-Piperaquine Market Forecast and Analysis
7.6. ARTESUNATE-MEFLOQUINE
7.6.1. Overview
7.6.2. Artesunate-Mefloquine Market Forecast and Analysis
7.7. ARTESUNATE-SULFADOXINE-PYRIMETHAMINE
7.7.1. Overview
7.7.2. Artesunate-Sulfadoxine-Pyrimethamine Market Forecast and Analysis
7.8. PYRONARIDINE-ARTESUNATE
7.8.1. Overview
7.8.2. Pyronaridine-Artesunate Market Forecast and Analysis
8. ARTEMISININ COMBINATION THERAPY MARKET - REVENUE AND FORECASTS TO 2028 - DISTRIBUTION CHANNELS
8.1. OVERVIEW
8.2. DISTRIBUTION CHANNELS MARKET FORECASTS AND ANALYSIS
8.3. RETAIL PHARMACY
8.3.1. Overview
8.3.2. Retail pharmacy Market Forecast and Analysis
8.4. HOSPITALS
8.4.1. Overview
8.4.2. Hospitals Market Forecast and Analysis
8.5. OTHERS
8.5.1. Overview
8.5.2. Others Market Forecast and Analysis
9. ARTEMISININ COMBINATION THERAPY MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
9.1. NORTH AMERICA
9.1.1 North America Artemisinin Combination Therapy Market Overview
9.1.2 North America Artemisinin Combination Therapy Market Forecasts and Analysis
9.1.3 North America Artemisinin Combination Therapy Market Forecasts and Analysis - By Type
9.1.4 North America Artemisinin Combination Therapy Market Forecasts and Analysis - By Distribution Channels
9.1.5 North America Artemisinin Combination Therapy Market Forecasts and Analysis - By Countries
9.1.5.1 United States Artemisinin Combination Therapy Market
9.1.5.1.1 United States Artemisinin Combination Therapy Market by Type
9.1.5.1.2 United States Artemisinin Combination Therapy Market by Distribution Channels
9.1.5.2 Canada Artemisinin Combination Therapy Market
9.1.5.2.1 Canada Artemisinin Combination Therapy Market by Type
9.1.5.2.2 Canada Artemisinin Combination Therapy Market by Distribution Channels
9.1.5.3 Mexico Artemisinin Combination Therapy Market
9.1.5.3.1 Mexico Artemisinin Combination Therapy Market by Type
9.1.5.3.2 Mexico Artemisinin Combination Therapy Market by Distribution Channels
9.2. EUROPE
9.2.1 Europe Artemisinin Combination Therapy Market Overview
9.2.2 Europe Artemisinin Combination Therapy Market Forecasts and Analysis
9.2.3 Europe Artemisinin Combination Therapy Market Forecasts and Analysis - By Type
9.2.4 Europe Artemisinin Combination Therapy Market Forecasts and Analysis - By Distribution Channels
9.2.5 Europe Artemisinin Combination Therapy Market Forecasts and Analysis - By Countries
9.2.5.1 Germany Artemisinin Combination Therapy Market
9.2.5.1.1 Germany Artemisinin Combination Therapy Market by Type
9.2.5.1.2 Germany Artemisinin Combination Therapy Market by Distribution Channels
9.2.5.2 France Artemisinin Combination Therapy Market
9.2.5.2.1 France Artemisinin Combination Therapy Market by Type
9.2.5.2.2 France Artemisinin Combination Therapy Market by Distribution Channels
9.2.5.3 Italy Artemisinin Combination Therapy Market
9.2.5.3.1 Italy Artemisinin Combination Therapy Market by Type
9.2.5.3.2 Italy Artemisinin Combination Therapy Market by Distribution Channels
9.2.5.4 Spain Artemisinin Combination Therapy Market
9.2.5.4.1 Spain Artemisinin Combination Therapy Market by Type
9.2.5.4.2 Spain Artemisinin Combination Therapy Market by Distribution Channels
9.2.5.5 United Kingdom Artemisinin Combination Therapy Market
9.2.5.5.1 United Kingdom Artemisinin Combination Therapy Market by Type
9.2.5.5.2 United Kingdom Artemisinin Combination Therapy Market by Distribution Channels
9.3. ASIA-PACIFIC
9.3.1 Asia-Pacific Artemisinin Combination Therapy Market Overview
9.3.2 Asia-Pacific Artemisinin Combination Therapy Market Forecasts and Analysis
9.3.3 Asia-Pacific Artemisinin Combination Therapy Market Forecasts and Analysis - By Type
9.3.4 Asia-Pacific Artemisinin Combination Therapy Market Forecasts and Analysis - By Distribution Channels
9.3.5 Asia-Pacific Artemisinin Combination Therapy Market Forecasts and Analysis - By Countries
9.3.5.1 Australia Artemisinin Combination Therapy Market
9.3.5.1.1 Australia Artemisinin Combination Therapy Market by Type
9.3.5.1.2 Australia Artemisinin Combination Therapy Market by Distribution Channels
9.3.5.2 China Artemisinin Combination Therapy Market
9.3.5.2.1 China Artemisinin Combination Therapy Market by Type
9.3.5.2.2 China Artemisinin Combination Therapy Market by Distribution Channels
9.3.5.3 India Artemisinin Combination Therapy Market
9.3.5.3.1 India Artemisinin Combination Therapy Market by Type
9.3.5.3.2 India Artemisinin Combination Therapy Market by Distribution Channels
9.3.5.4 Japan Artemisinin Combination Therapy Market
9.3.5.4.1 Japan Artemisinin Combination Therapy Market by Type
9.3.5.4.2 Japan Artemisinin Combination Therapy Market by Distribution Channels
9.3.5.5 South Korea Artemisinin Combination Therapy Market
9.3.5.5.1 South Korea Artemisinin Combination Therapy Market by Type
9.3.5.5.2 South Korea Artemisinin Combination Therapy Market by Distribution Channels
9.4. MIDDLE EAST AND AFRICA
9.4.1 Middle East and Africa Artemisinin Combination Therapy Market Overview
9.4.2 Middle East and Africa Artemisinin Combination Therapy Market Forecasts and Analysis
9.4.3 Middle East and Africa Artemisinin Combination Therapy Market Forecasts and Analysis - By Type
9.4.4 Middle East and Africa Artemisinin Combination Therapy Market Forecasts and Analysis - By Distribution Channels
9.4.5 Middle East and Africa Artemisinin Combination Therapy Market Forecasts and Analysis - By Countries
9.4.5.1 South Africa Artemisinin Combination Therapy Market
9.4.5.1.1 South Africa Artemisinin Combination Therapy Market by Type
9.4.5.1.2 South Africa Artemisinin Combination Therapy Market by Distribution Channels
9.4.5.2 Saudi Arabia Artemisinin Combination Therapy Market
9.4.5.2.1 Saudi Arabia Artemisinin Combination Therapy Market by Type
9.4.5.2.2 Saudi Arabia Artemisinin Combination Therapy Market by Distribution Channels
9.4.5.3 U.A.E Artemisinin Combination Therapy Market
9.4.5.3.1 U.A.E Artemisinin Combination Therapy Market by Type
9.4.5.3.2 U.A.E Artemisinin Combination Therapy Market by Distribution Channels
9.5. SOUTH AND CENTRAL AMERICA
9.5.1 South and Central America Artemisinin Combination Therapy Market Overview
9.5.2 South and Central America Artemisinin Combination Therapy Market Forecasts and Analysis
9.5.3 South and Central America Artemisinin Combination Therapy Market Forecasts and Analysis - By Type
9.5.4 South and Central America Artemisinin Combination Therapy Market Forecasts and Analysis - By Distribution Channels
9.5.5 South and Central America Artemisinin Combination Therapy Market Forecasts and Analysis - By Countries
9.5.5.1 Brazil Artemisinin Combination Therapy Market
9.5.5.1.1 Brazil Artemisinin Combination Therapy Market by Type
9.5.5.1.2 Brazil Artemisinin Combination Therapy Market by Distribution Channels
9.5.5.2 Argentina Artemisinin Combination Therapy Market
9.5.5.2.1 Argentina Artemisinin Combination Therapy Market by Type
9.5.5.2.2 Argentina Artemisinin Combination Therapy Market by Distribution Channels
10. INDUSTRY LANDSCAPE
10.1. MERGERS AND ACQUISITIONS
10.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
10.3. NEW PRODUCT LAUNCHES
10.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
11. ARTEMISININ COMBINATION THERAPY MARKET, KEY COMPANY PROFILES
11.1. HOVID-INTEGRATED GLOBAL PHARMACEUTICAL PARTNER
11.1.1. Key Facts
11.1.2. Business Description
11.1.3. Products and Services
11.1.4. Financial Overview
11.1.5. SWOT Analysis
11.1.6. Key Developments
11.2. IPCA LABORATORIES LTD
11.2.1. Key Facts
11.2.2. Business Description
11.2.3. Products and Services
11.2.4. Financial Overview
11.2.5. SWOT Analysis
11.2.6. Key Developments
11.3. ASPEN HOLDINGS
11.3.1. Key Facts
11.3.2. Business Description
11.3.3. Products and Services
11.3.4. Financial Overview
11.3.5. SWOT Analysis
11.3.6. Key Developments
11.4. AJANTA PHARMA
11.4.1. Key Facts
11.4.2. Business Description
11.4.3. Products and Services
11.4.4. Financial Overview
11.4.5. SWOT Analysis
11.4.6. Key Developments
11.5. NOVARTIS AG
11.5.1. Key Facts
11.5.2. Business Description
11.5.3. Products and Services
11.5.4. Financial Overview
11.5.5. SWOT Analysis
11.5.6. Key Developments
11.6. SANOFI
11.6.1. Key Facts
11.6.2. Business Description
11.6.3. Products and Services
11.6.4. Financial Overview
11.6.5. SWOT Analysis
11.6.6. Key Developments
11.7. CIPLA INC
11.7.1. Key Facts
11.7.2. Business Description
11.7.3. Products and Services
11.7.4. Financial Overview
11.7.5. SWOT Analysis
11.7.6. Key Developments
11.8. KPC PHARMACEUTICALS
11.8.1. Key Facts
11.8.2. Business Description
11.8.3. Products and Services
11.8.4. Financial Overview
11.8.5. SWOT Analysis
11.8.6. Key Developments
11.9. MYLAN N.V
11.9.1. Key Facts
11.9.2. Business Description
11.9.3. Products and Services
11.9.4. Financial Overview
11.9.5. SWOT Analysis
11.9.6. Key Developments
11.10. SUN PHARMACEUTICAL INDUSTRIES LTD
11.10.1. Key Facts
11.10.2. Business Description
11.10.3. Products and Services
11.10.4. Financial Overview
11.10.5. SWOT Analysis
11.10.6. Key Developments
12. APPENDIX
12.1. ABOUT THE INSIGHT PARTNERS
12.2. GLOSSARY OF TERMS
1. Hovid-Integrated Global Pharmaceutical Partner
2. Ipca Laboratories Ltd
3. Aspen Holdings
4. AJANTA PHARMA
5. Novartis AG
6. Sanofi
7. Cipla Inc
8. KPC Pharmaceuticals
9. Mylan N.V
10. Sun Pharmaceutical Industries Ltd
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Get Free Sample For